{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:30:12Z","timestamp":1794893412341,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bonr.2024.101822","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T17:39:10Z","timestamp":1735666750000},"page":"101822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical features and treatment of hypophosphatemia and associated complications induced by Phosphaturic mesenchymal tumors: A case series of six patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Guoqiang","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangsheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runmin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengbo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0005","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin. Nucl. Med."},{"issue":"9","key":"10.1016\/j.bonr.2024.101822_bb0010","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.bonr.2024.101822_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2967\/jnmt.116.177873","article-title":"177Lu-DOTATATE PRRT in recurrent Skull-Base Phosphaturic mesenchymal tumor causing Osteomalacia: a potential application of PRRT beyond neuroendocrine tumors","volume":"44","author":"Basu","year":"2016","journal-title":"J. Nucl. Med. Technol."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/wjnm.WJNM_92_18","article-title":"(68)Ga-DOTATATE positron emission tomography\/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia","volume":"19","author":"Bhalla","year":"2020","journal-title":"World J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.bonr.2024.101822_bb0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","article-title":"Phosphaturic mesenchymal tumors: what an endocrinologist should know","volume":"41","author":"Boland","year":"2018","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"10.1016\/j.bonr.2024.101822_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00256-018-3014-5","article-title":"Imaging features of phosphaturic mesenchymal tumors","volume":"48","author":"Broski","year":"2019","journal-title":"Skeletal Radiol."},{"issue":"3","key":"10.1016\/j.bonr.2024.101822_bb0040","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bonr.2024.101822_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116077","article-title":"Tumor induced osteomalacia: a single center experience on 17 patients","volume":"152","author":"Crotti","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0050","first-page":"201","volume":"34","author":"Crotti","year":"2023","journal-title":"Long-term use of burosumab for the treatment of tumor-induced osteomalacia."},{"issue":"10","key":"10.1016\/j.bonr.2024.101822_bb0055","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced Osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bonr.2024.101822_bb0060","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/sdi.12411","article-title":"Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease","volume":"28","author":"Felsenfeld","year":"2015","journal-title":"Semin. Dial."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced Osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.bonr.2024.101822_bb0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1507\/endocrj.EJ17-0177","article-title":"Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23","volume":"64","author":"Hana","year":"2017","journal-title":"Endocr. J."},{"issue":"12","key":"10.1016\/j.bonr.2024.101822_bb0080","first-page":"1609","volume":"126","author":"Hussein","year":"2021","journal-title":"Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway."},{"issue":"2","key":"10.1016\/j.bonr.2024.101822_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101851","article-title":"The pathophysiology of hypophosphatemia","volume":"38","author":"Ito","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bonr.2024.101822_bb0090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.bonr.2024.101822_bb0095","first-page":"627","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"Burosumab for the Treatment of Tumor-Induced Osteomalacia"},{"issue":"3","key":"10.1016\/j.bonr.2024.101822_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur","year":"2023","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.bonr.2024.101822_bb0105","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bonr.2024.101822_bb0110","first-page":"758","article-title":"Genetic diseases of renal phosphate handling","volume":"57","author":"Kaneko","year":"2015","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"6","key":"10.1016\/j.bonr.2024.101822_bb0115","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.kint.2021.08.030","article-title":"Kidney toxicity of phosphate: is that crystal clear yet?","volume":"100","author":"Letavernier","year":"2021","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bonr.2024.101822_bb0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.humpath.2003.12.005","article-title":"Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing","volume":"35","author":"Markowitz","year":"2004","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0004-27302006000100021","article-title":"Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature","volume":"50","author":"Moreira","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ol.2014.2081","article-title":"Malignant phosphaturic mesenchymal tumor of the pelvis: a report of two cases","volume":"8","author":"Morimoto","year":"2014","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bonr.2024.101822_bb0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/js.2016-1088","article-title":"Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced Osteomalacia","volume":"1","author":"Nair","year":"2017","journal-title":"J. Endocr. Soc."},{"issue":"10","key":"10.1016\/j.bonr.2024.101822_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2169\/internalmedicine.47.0745","article-title":"Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23","volume":"47","author":"Nasu","year":"2008","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.bonr.2024.101822_bb0145","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2024.101822_bb0150","first-page":"1224","volume":"108","author":"Ni","year":"2023","journal-title":"Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia."},{"key":"10.1016\/j.bonr.2024.101822_bb0155","doi-asserted-by":"crossref","unstructured":"Pelletier, K., et al., Localization of ectopic fibroblast growth factor 23 production in tumor-induced osteomalacia using selective venous samplings. Clin Nephrol, 2017. 87 (2017)(2): p. 107\u2013110.","DOI":"10.5414\/CN108981"},{"issue":"26","key":"10.1016\/j.bonr.2024.101822_bb0160","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bonr.2024.101822_bb0165","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies","volume":"12","author":"Shane","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bonr.2024.101822_bb0170","first-page":"1860","article-title":"Malignant phosphaturic mesenchymal tumor of the larynx","volume":"121","author":"Sidell","year":"2011","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.bonr.2024.101822_bb0175","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bonr.2024.101822_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/CH-200921","article-title":"Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review","volume":"77","author":"Xian","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"12","key":"10.1016\/j.bonr.2024.101822_bb0185","first-page":"1937","article-title":"A case of hyperparathyroidism secondary to tumor-induced osteomalacia","volume":"48","author":"Yang","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187224000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187224000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:55:51Z","timestamp":1741924551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187224000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"alternative-id":["S2352187224000895"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2024.101822","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and treatment of hypophosphatemia and associated complications induced by Phosphaturic mesenchymal tumors: A case series of six patients","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2024.101822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101822"}}